Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Clinical Research›Odds Ratio
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Odds Ratio

Clinical Research · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

The ratio of two odds.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (818 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Odds Ratios; Cross-Product Ratio; Cross Product Ratio; Cross-Product Ratios; Ratio, Cross-Product; Ratios, Cross-Product; Relative Odds; Odds, Relative.

Where it fits in the MeSH classification

Broader topics
Probability

Research landscape

PubMed indexes 100,085 records tagged with the MeSH heading “Odds Ratio” (counts retrieved 2026-10-29). 9,309 of them (9.3%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 53,602 records.

Reviews account for 11,714 records (11.7%) and meta-analyses for 10,159. Randomized controlled trials number 2,887 (2.9%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 9,520 records; 2000-2009: 27,654 records; 2010-2019: 53,602 records; 2020 onward: 9,309 records9,520through 199927,6542000-200953,6022010-20199,3092020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19999,520
2000-200927,654
2010-201953,602
2020 onward9,309
Share of records by publication typeReviews: 11.7 percent; Meta-analyses: 10.2 percent; Randomized controlled trials: 2.9 percentReviews11.7% (11,714)Meta-analyses10.2% (10,159)Randomized controlled trials2.9% (2,887)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 100,085 PubMed records
TypeRecordsShare
Reviews11,71411.7%
Meta-analyses10,15910.2%
Randomized controlled trials2,8872.9%

Method: PubMed query "Odds Ratio"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in clinical research

Research methods determine how much a result can be trusted. Randomized trials guard against confounding, systematic reviews and meta-analyses combine many studies, and observational designs are valuable but can show only association. Reporting standards, trial registration and pre-specified outcomes reduce bias. When reading about a method, ask what problem it is designed to solve and which problems it does not solve.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Bias in odds ratios by logistic regression modelling and sample size
Nemes S, Jonasson JM, Genell A, Steineck G
2009Research article
Design not recorded in structured metadata
239cc by
PMID 19635144 · DOI · PMC2724427
Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size
Pirracchio R, Resche-Rigon M, Chevret S
2012Research article
Design not recorded in structured metadata
176cc by
PMID 22646911 · DOI · PMC3511219
A comparison of seven random-effects models for meta-analyses that estimate the summary odds ratio
Jackson D, Law M, Stijnen T, Viechtbauer W, White IR
2018Research article
Design not recorded in structured metadata
145cc by
PMID 29315733 · DOI · PMC5841569
Collapsibility in case-control studies
Pearce N
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42217164 · DOI · PMC13221832

Bias in odds ratios by logistic regression modelling and sample size [1]

Research article Nemes S, Jonasson JM, Genell A, Steineck G · · 2009 · cited 239 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundIn epidemiological studies researchers use logistic regression as an analytical tool to study the association of a binary outcome to a set of possible exposures.
Closing excerpt
ConclusionIf several small studies are pooled without consideration of the bias introduced by the inherent mathematical properties of the logistic regression model, researchers may be mislead to erroneous interpretation of the results.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (118 words)

BackgroundIn epidemiological studies researchers use logistic regression as an analytical tool to study the association of a binary outcome to a set of possible exposures.MethodsUsing a simulation study we illustrate how the analytically derived bias of odds ratios modelling in logistic regression varies as a function of the sample size.ResultsLogistic regression overestimates odds ratios in studies with small to moderate samples size. The small sample size induced bias is a systematic one, bias away from null. Regression coefficient estimates shifts away from zero, odds ratios from one.ConclusionIf several small studies are pooled without consideration of the bias introduced by the inherent mathematical properties of the logistic regression model, researchers may be mislead to erroneous interpretation of the results.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 19635144 · DOI · PMC2724427

Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size [2]

Research article Pirracchio R, Resche-Rigon M, Chevret S · · 2012 · cited 176 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundPropensity score (PS) methods are increasingly used, even when sample sizes are small or treatments are seldom used.
Closing excerpt
ConclusionEven in case of small study samples or low prevalence of treatment, PS-matching and IPTW can yield correct estimations of treatment effect unless the true confounders and the variables related only to the outcome are not included in the PS model.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (243 words)

BackgroundPropensity score (PS) methods are increasingly used, even when sample sizes are small or treatments are seldom used. However, the relative performance of the two mainly recommended PS methods, namely PS-matching or inverse probability of treatment weighting (IPTW), have not been studied in the context of small sample sizes.MethodsWe conducted a series of Monte Carlo simulations to evaluate the influence of sample size, prevalence of treatment exposure, and strength of the association between the variables and the outcome and/or the treatment exposure, on the performance of these two methods.ResultsDecreasing the sample size from 1,000 to 40 subjects did not substantially alter the Type I error rate, and led to relative biases below 10%. The IPTW method performed better than the PS-matching down to 60 subjects. When N was set at 40, the PS matching estimators were either similarly or even less biased than the IPTW estimators. Including variables unrelated to the exposure but related to the outcome in the PS model decreased the bias and the variance as compared to models omitting such variables. Excluding the true confounder from the PS model resulted, whatever the method used, in a significantly biased estimation of treatment effect. These results were illustrated in a real dataset.ConclusionEven in case of small study samples or low prevalence of treatment, PS-matching and IPTW can yield correct estimations of treatment effect unless the true confounders and the variables related only to the outcome are not included in the PS model.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 22646911 · DOI · PMC3511219

A comparison of seven random-effects models for meta-analyses that estimate the summary odds ratio [3]

Research article Jackson D, Law M, Stijnen T, Viechtbauer W, White IR · · 2018 · cited 145 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Comparative trials that report binary outcome data are commonly pooled in systematic reviews and meta-analyses.
Closing excerpt
Only one of the models that we investigate is found to perform poorly so that any of the other models could be considered for either the primary or the sensitivity analysis.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (235 words)

Comparative trials that report binary outcome data are commonly pooled in systematic reviews and meta-analyses. This type of data can be presented as a series of 2-by-2 tables. The pooled odds ratio is often presented as the outcome of primary interest in the resulting meta-analysis. We examine the use of 7 models for random-effects meta-analyses that have been proposed for this purpose. The first of these models is the conventional one that uses normal within-study approximations and a 2-stage approach. The other models are generalised linear mixed models that perform the analysis in 1 stage and have the potential to provide more accurate inference. We explore the implications of using these 7 models in the context of a Cochrane Review, and we also perform a simulation study. We conclude that generalised linear mixed models can result in better statistical inference than the conventional 2-stage approach but also that this type of model presents issues and difficulties. These challenges include more demanding numerical methods and determining the best way to model study specific baseline risks. One possible approach for analysts is to specify a primary model prior to performing the systematic review but also to present the results using other models in a sensitivity analysis. Only one of the models that we investigate is found to perform poorly so that any of the other models could be considered for either the primary or the sensitivity analysis.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29315733 · DOI · PMC5841569

Collapsibility in case-control studies [4]

Research article Pearce N · · 2026

Abstract reading summary — source excerpts
Opening excerpt
It is well-established that the odds ratio (OR) is non-collapsible and that adjustment of the OR for a risk factor can produce a change in the main effect estimate even when there is no confounding.
Closing excerpt
Moreover, if the disease under study is rare (in the cohort study), all three methods produce case-control ORs that are approximately collapsible.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (222 words)

It is well-established that the odds ratio (OR) is non-collapsible and that adjustment of the OR for a risk factor can produce a change in the main effect estimate even when there is no confounding. In contrast, the risk ratio (RR) is collapsible, whereas the rate ratio is non-collapsible, but usually to a lesser extent than is the case with ORs. However, almost all discussions of non-collapsibility have been conducted in the context of effect measures in cohort studies. In this paper, I consider non-collapsibility in case-control studies where the OR inherits the collapsibility or non-collapsibility of the ratio effect measure that the study was designed to estimate. This is most clearly illustrated in the situation of a closed cohort with a fixed follow-up time. In this situation, choosing controls by cumulative incidence sampling estimates the OR in the corresponding cohort study, and therefore the resulting case-control OR is non-collapsible. Choosing controls by case-cohort sampling estimates the cohort study RR, and the resulting case-control OR is collapsible. Choosing controls by density sampling (perhaps the most common approach) estimates the cohort study rate ratio, and the resulting case-control OR is non-collapsible, but to a lesser extent than for cumulative incidence sampling. Moreover, if the disease under study is rare (in the cohort study), all three methods produce case-control ORs that are approximately collapsible.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42217164 · DOI · PMC13221832

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker [5]
    Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P · Am J Epidemiol · 2004 · cited 913 times (Europe PMC)
  • Research article The reporting odds ratio and its advantages over the proportional reporting ratio [6]
    Rothman KJ, Rothman KJ, Lanes S, Sacks ST · Pharmacoepidemiol Drug Saf · 2004 · cited 816 times (Europe PMC)
  • Research article Statistics notes. The odds ratio [7]
    Bland JM, Altman DG · BMJ · 2000 · cited 742 times (Europe PMC)
  • Research article When can odds ratios mislead? [8]
    Davies HT, Crombie IK, Tavakoli M · BMJ · 1998 · cited 618 times (Europe PMC)
  • Research article The relative merits of risk ratios and odds ratios [9]
    Cummings P · Arch Pediatr Adolesc Med · 2009 · cited 370 times (Europe PMC)
  • Research article Betting odds and genetic associations [10]
    Thomas DC, Clayton DG · J Natl Cancer Inst · 2004 · cited 119 times (Europe PMC)

References

  1. Nemes S, Jonasson JM, Genell A, Steineck G. Bias in odds ratios by logistic regression modelling and sample size. . 2009. PMID 19635144 · DOI · PMC2724427
  2. Pirracchio R, Resche-Rigon M, Chevret S. Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size. . 2012. PMID 22646911 · DOI · PMC3511219
  3. Jackson D, Law M, Stijnen T, Viechtbauer W, White IR. A comparison of seven random-effects models for meta-analyses that estimate the summary odds ratio. . 2018. PMID 29315733 · DOI · PMC5841569
  4. Pearce N. Collapsibility in case-control studies. . 2026. PMID 42217164 · DOI · PMC13221832
  5. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004. PMID 15105181 · DOI
  6. Rothman KJ, Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004. PMID 15317031 · DOI
  7. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000. PMID 10827061 · DOI · PMC1127651
  8. Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead?. BMJ. 1998. PMID 9550961 · DOI · PMC1112884
  9. Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009. PMID 19414690 · DOI
  10. Thomas DC, Clayton DG. Betting odds and genetic associations. J Natl Cancer Inst. 2004. PMID 15026459 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Risk AssessmentClinical Research
  • Cardiometabolic Risk FactorsClinical Research
  • Risk FactorsClinical Research
  • Genetic Risk ScoreGenetics and Genomics
  • Cluster AnalysisClinical Research
  • Confidence IntervalsClinical Research

All 98 articles in Clinical Research →

At a glance

100,085
PubMed records on this heading
9%
published since 2020
11,714
review articles
2,887
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Risk AssessmentClinical Research
  • Cardiometabolic Risk FactorsClinical Research
  • Risk FactorsClinical Research
  • Genetic Risk ScoreGenetics and Genomics
  • Cluster AnalysisClinical Research

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support